Kestrel Therapeutics

0 followers


Our goal is to bring new therapy to cancer’s most frequently mutated oncogenic target. Kestrel is discovering and developing new molecules to treat intractable cancers. We are starting with potent inhibitors of pan-oncogenic-RAS. We rely on exceptional science, and our focus, always, is on patien... Read more

Headquarters

Boston, US

Employees

11-50

Links

Org chart

Frank Haluska
President And CEO

Frank Haluska

Collapse
Mark Bilodeau
Chief Scientific Officer
Ross Pettit
Svp, Head Of Development Operations
Omar A.
Vice President
Shyam Karki
Vice President And Head Of CMC